The Finlay Institute is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay, who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.
In response to fight against COVID-19, Finlay Institute has developed the Soberana 02. In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.
References
Chaves-Carballo, Enrique (October 2005). "Carlos Finlay and Yellow Fever: Triumph over Adversity". Military Medicine. 170 (10): 881–885. doi:10.7205/MILMED.170.10.881. PMID 16435764. https://doi.org/10.7205%2FMILMED.170.10.881 ↩
Reardon, Sara (22 November 2021). "Cuba's bet on home-grown COVID vaccines is paying off". Nature. 600 (7887): 15–16. Bibcode:2021Natur.600...15R. doi:10.1038/d41586-021-03470-x. PMID 34811530. S2CID 244491102. https://doi.org/10.1038%2Fd41586-021-03470-x ↩
Cuba pospone el inicio de la vacunación con Soberana 14ymedio, 8 mars 2021 https://www.14ymedio.com/cienciaytecnologia/Cuba-pospone-inicio-vacunacion-Soberana_0_3053694604.html ↩